+48 61 839 24 75

Development of the covid-19 vaccine black market

On the Internet it is easy to find a branch of offers regarding the sale of drugs. Unfortunately, many of them are illegal. It means that the medicines come from the so-called black market. The black market for Covid-19 vaccines is also fastly growing.

On the Internet it is easy to find a branch of offers regarding the sale of drugs. Unfortunately, many of them are illegal. It means that the medicines come from the so-called black market. The black market for Covid-19 vaccines is also fastly growing. The number of illegal vaccine ampoules has increased to such a scale that the President of the European Commission, Ursula von der Leyen, recently had to warn Member States about pharmaceutical products which had been sold by unauthorised drug dealers. However, the demand for illegal medicines has always been high. In 2019 the Falsified Medicines Directive was introduced, which supposed to reduce the illegal chain of drug distribution. However, it is also crucial to introduce the educational measures on legal sources of drug supply and their protection against counterfeiting, so that the patient is well aware of how harmful it can be to buy such products (medicines or vaccines) on the black market.

Can Covid-19 vaccines offered on the black market might be dangerous for human health?

Due to a massive amount of Covid-19 vaccines on the black market, customers who buy them online or in any other way must be aware that they can never be 100% sure what the ampoule actually contains when it comes from an illegal source. To fight against it, all prescription medicines are delivered in safe packaging under the so-called Temper evidence, which makes it easy to identify if a particular medicinal product has not been opened before and, for example, replaced in a package. Access to protected medicines is possible only after the destruction or damage of such a device.

Serialization of Covid-19 vaccines ampoules - the ultimate black market weapon!

Pharmaceutical companies often use an additional protection to defend themselves against international drug counterfeiting. We are referring, of course, to the serialisation of medicines, medical devices and pharmaceuticals, which makes it possible to better control all drug sales channels. During the packaging process of products at high risk of counterfeiting – e.g. Covid-19 vaccines – such additional protection (2D matrix codes) are used as part of the serialisation process. Serialised pharmaceutical products can be easily verified and distinguished from the falsified products purchased on the black market. Due to this process, we are sure that only authentic, officially approved medicines go to the legal market.

Informational campaigns in the local society on drug safety

What has been highlighted in the introduction, patients need to be aware of what pharmaceutical products they can safely consume. That is actually the reason why our company provide informational campaigns in the local press and social media about the safety of medicines. We also create audiovisual materials for publication on social media. We believe that our social responsibility as a contract manufacturer of medicines is to carry out such information activities. Especially now when the black market for COVID vaccines is expanding.

ABOUT US

ABOUT US

Prespack offers specialised services of contract packing, repacking and serialisation for EU-originating medicinal products, psychotropic substances and products that require cold chain storage.

 

We provide our services based on a manufacturing authorization for medicinal products and a GMP certificate from the Polish Chief Pharmaceutical Inspector. We offer serialization solutions to marketing authorization holders (MAHs), including those involved in parallel importation (PI MAHs).

Usługi

OUR SERVICES

Prespack offers contract services to pharmaceutical companies, including packing, repacking medicinal products into individual packs, and serialisation. We provide our services pursuant to a manufacturing and import authorisation and a GMP certificate. We carry out the following operations as part of our manufacturing process:

SERIALISATION

SERIALISATION

9 February 2019 saw the entry into force in Poland of Commission Delegated Regulation (EU) 2016/161 which requires medicinal product manufacturers to use certain safety features on their products. This posed a serious challenge to pharmaceutical and contract manufacturers who had to bring their manufacturing processes and their technical and computer infrastructure in line with the new regulatory standards.

PRODUCTION OF PACKAGING MATERIALS

PRODUCTION OF PACKAGING MATERIALS

We can offer an added value to marketing authorisation holders (MAHs), including those involved in parallel importation (PI MAHs). Our in-house printing facilities are an additional advantage in that we can offer end-to-end production services for packaging materials, including internal logistics and subsequent customising processes.

QUALITY POLICY

QUALITY POLICY

All our manufacturing operations are carried out based on the current GMP guidelines. With our state-of-the-art technology and the Quality Assurance System, we can guarantee product safety and competitive service. We commit all our efforts and resources to make sure that our clients’ final products are as expected by them and fully compatible with Directive 2011/62/EU.

CAREER

CAREER

We are a fast growing business and we are open to new challenges. This makes us the perfect place to build and develop your career at. Choose a job that is full of challenges and will let you step up your skills and qualifications. We create quality in the workplace and we carry out our work with enthusiasm and commitment.

NEWS

What will the year 2024 bring for the pharmaceutical industry? Outsourcing of packaging services is important like never before.

What will the year 2024 bring for the pharmaceutical industry? Outsourcing of packaging services is important like never before.


Operating in the pharmaceutical market, we are observing the changes and trends…

What is the outsourcing of contract packaging services and what benefits does it bring to pharmaceutical companies?

What is the outsourcing of contract packaging services and what benefits does it bring to pharmaceutical companies?


In the current economic situation, companies are seeking to optimize the costs…

CONTACT

ikony kontakt pin

Prespack sp. z o.o. 
Sadowa 38 
60-185 Skórzewo

ikony kontakt pin

Phone: +48 61 839 24 75
Office: +48 606 841 900
Customer service: +48 517 344 350
Warehouse: +48 603 292 499+48 604 802 929

ikony kontakt pin

NIP: 7812016420
REGON: 387877393
KRS: 0000877047
E-mail: office@prespack.pl

Wysokość kapitału zakładowego: 360 000,00 zł, Sąd Rejonowy Poznań – Nowe Miasto i Wilda w Poznaniu, VIII Wydział Gospodarczy Krajowego Rejestru Sądowego